Velosbio Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa)

This study tested a drug called VLS-101 in people with advanced solid tumors, including breast, lung, stomach, pancreatic, and ovarian cancers that had stopped responding to other treatments. The goal was to see if the drug could shrink tumors. However, the trial was stopped earl…